Andrew R. Boll, Chief Financial Officer at Imprimis Pharmaceuticals, Inc. (IMMY), bought 39,000 shares at $1.79 ($70K) on 2016-12-19, disclosed to the SEC on 2016-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |